GUGGENHEIM CAPITAL LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,453,949
-1.4%
14,274
-2.3%
0.01%
+8.3%
Q2 2023$1,474,699
+0.5%
14,614
-8.4%
0.01%0.0%
Q1 2023$1,467,492
+39.2%
15,951
+37.3%
0.01%
+33.3%
Q4 2022$1,054,257
+142.4%
11,621
+103.3%
0.01%
+125.0%
Q3 2022$435,000
-5.0%
5,716
+5.3%
0.00%0.0%
Q2 2022$458,000
-11.9%
5,427
-8.5%
0.00%
+33.3%
Q1 2022$520,000
-37.2%
5,931
-37.3%
0.00%
-25.0%
Q4 2021$828,000
+29.6%
9,458
+21.1%
0.00%0.0%
Q3 2021$639,000
-22.1%
7,810
-13.1%
0.00%
-20.0%
Q2 2021$820,000
-19.4%
8,989
-24.5%
0.01%
-28.6%
Q1 2021$1,018,000
-34.6%
11,909
-27.8%
0.01%
-30.0%
Q4 2020$1,556,000
-22.1%
16,486
-28.2%
0.01%
-28.6%
Q3 2020$1,997,000
-19.2%
22,963
-18.9%
0.01%
-26.3%
Q2 2020$2,473,000
+1.7%
28,308
-4.0%
0.02%
-20.8%
Q1 2020$2,432,000
-22.3%
29,498
-10.8%
0.02%0.0%
Q4 2019$3,130,000
-6.8%
33,055
-14.5%
0.02%
-11.1%
Q3 2019$3,358,000
+7.0%
38,643
+12.4%
0.03%
+3.8%
Q2 2019$3,139,000
-26.2%
34,379
-22.2%
0.03%
-25.7%
Q1 2019$4,251,000
+52.4%
44,216
+36.0%
0.04%
+45.8%
Q4 2018$2,790,000
-29.1%
32,512
-28.8%
0.02%
-7.7%
Q3 2018$3,934,000
+30.0%
45,661
+14.1%
0.03%
+30.0%
Q2 2018$3,025,000
-13.9%
40,027
-7.9%
0.02%
+122.2%
Q1 2018$3,515,000
-1.1%
43,471
+2.7%
0.01%
+12.5%
Q4 2017$3,555,000
-17.1%
42,333
-15.3%
0.01%
-20.0%
Q3 2017$4,290,000
+6.8%
49,964
+3.8%
0.01%
-9.1%
Q2 2017$4,018,000
+23.4%
48,154
+9.9%
0.01%
+22.2%
Q1 2017$3,255,000
+14.7%
43,827
+12.5%
0.01%
+12.5%
Q4 2016$2,837,000
-52.5%
38,956
-48.5%
0.01%
-57.9%
Q3 2016$5,973,000
+24.4%
75,648
+30.1%
0.02%
+26.7%
Q2 2016$4,800,000
-12.6%
58,168
-23.2%
0.02%
-11.8%
Q1 2016$5,489,000
-23.0%
75,767
-8.5%
0.02%
-19.0%
Q4 2015$7,128,000
-44.4%
82,829
-40.6%
0.02%
-46.2%
Q3 2015$12,825,000
-18.5%
139,503
-12.8%
0.04%0.0%
Q2 2015$15,727,000
+1.8%
159,928
+2.1%
0.04%
+5.4%
Q1 2015$15,448,000
+4.0%
156,656
-2.3%
0.04%0.0%
Q4 2014$14,860,000
-12.4%
160,387
-10.9%
0.04%
-9.8%
Q3 2014$16,955,000
-1.5%
180,108
-5.3%
0.04%
-6.8%
Q2 2014$17,213,000
+8.3%
190,136
+1.7%
0.04%
-2.2%
Q1 2014$15,897,000
+23.5%
186,995
+16.8%
0.04%
+15.4%
Q4 2013$12,870,000
+32.7%
160,148
+26.7%
0.04%
+11.4%
Q3 2013$9,698,000
+22.5%
126,413
+12.9%
0.04%
+6.1%
Q2 2013$7,914,000111,9220.03%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders